Is Alibaba Headed Back to the IPO Price or Lower as Lock-Up Expirations Near?
At the right price, Alibaba probably is a tremendous long-term stock to have in an aggressive growth portfolio. The question is, what is that price?
At the right price, Alibaba probably is a tremendous long-term stock to have in an aggressive growth portfolio. The question is, what is that price?
Bought as a basket, these four companies could offer long-term investors a perfect compliment of stocks covering the health care sector.
We combined two Merrill Lunch ideas that secular contrarians should be long, or own now, and screened the firm's stocks universe for large-cap dividend yield stocks that are rated Buy.
24/7 Wall St. screened the recent RBC list of technology takeover candidates for five higher profile and more well-known stocks.
UBS analysts are focused on these three top companies to buy in the cybersecurity space. Despite some large upside moves, the analysts feel comfortable more upside lies ahead.
One area that makes sense for growth investors is the large cap pharmaceuticals. Here are some the top pharmaceutical stocks to buy now according to Jefferies.
RBC Capital Markets has prepared a massive list of companies that could be takeout candidates. The firm sees these energy stocks as potentially a good fit for an acquirer.
In a trend that seems somewhat locked into place, insiders continue to sell stock, though as we have seen most of this year, nobody is rushing to the exits, at least for now.
More and more we are noticing buyers of some energy and industrial names that have lagged the overall market gains. That is a good sign for investors.
Historically, industries in the consumer staples arena are the real beneficiaries of a drop in oil prices, especially when the savings rate rises.
A new research note from Jefferies makes the case that it is time for stocks with international exposure to begin to outperform.
While crude oil pricing has been a cruel mistress for the large integrateds and the independent exploration and production companies, it has been serving the refiners quite well, thank you.
If there was any segment that took a beating in 2014 in addition to the energy sector, it was the business development companies.
In a new and very in-depth research report from UBS, the stocks of only four semiconductor companies based in the United States are rated Buy.
24/7 Wall St. screened data on exploration and production companies in a new research note from Jefferies and found five likely to survive this oil price plunge.
Even with costs being slashed and share buybacks being halted, it appears that investors who have already taken a hit with share prices dropping should continue to get their quarterly dividend checks.
Here are the four top biotech stocks to buy now according to Deutsche Bank. These leaders have established drugs, solid pipelines and, most importantly, earnings.
With earnings season right around the corner for many retailers, the Deutsche Bank team has five top stock picks, some of which the analysts feel could beat current earnings expectations.
Cowen analyst Doug Cruetz made a fantastic call on a pair of mobile gaming stocks, and it could get ugly for short sellers.
The UBS CIO Wealth Management team makes a good case that investors should consider the stocks in the firm's Quality Growth at a Reasonable Price (Q-GARP) portfolio.